(Q37288443)

19 August 2017

Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma (English)

1 reference

esophageal squamous cell carcinoma

19 August 2017

1 reference

inferred from title

squamous cell carcinoma

1 reference

Pengfei Ren

1

1 reference

19 August 2017

Hua Ye

2

1 reference

19 August 2017

Liping Dai

3

1 reference

19 August 2017

Mei Liu

4

1 reference

19 August 2017

Xinxin Liu

5

1 reference

19 August 2017

Yurong Chai

6

1 reference

19 August 2017

Qing Shao

7

1 reference

19 August 2017

Yang Li

8

1 reference

19 August 2017

Ningjing Lei

9

1 reference

19 August 2017

Bo Peng

10

1 reference

19 August 2017

Wu Yao

11

1 reference

19 August 2017

Jianying Zhang

12

1 reference

19 August 2017

4 September 2013

1 reference

19 August 2017

1 reference

19 August 2017

30

1 reference

19 August 2017

5

1 reference

19 August 2017

2297-2303

1 reference

Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Immunogenicity of autoantigens

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Peroxiredoxin 1 and its role in cell signaling

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

The oligomeric conformation of peroxiredoxins links redox state to function.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Autoantibodies to tumor-associated antigens: reporters from the immune system

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

The reverse proteomics for identification of tumor antigens.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Cell signaling. H2O2, a necessary evil for cell signaling

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Improved approach to identify cancer-associated autoantigens

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3820583

Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients

20 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24009050

12 December 2020

inferred from PubMed ID database lookup

Proteomic identification of overexpressed PRDX 1 and its clinical implications in ovarian carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24009050

12 December 2020

inferred from PubMed ID database lookup

ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24009050

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.3892/OR.2013.2714

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

24009050

1 reference